European Union - English - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenem sodium - bacterial infections - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4.4 and 5.1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4.4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4.4).consideration should be given to official guidance on the appropriate use of antibacterial agents.

Canada - English - Health Canada

auro pharma inc - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems

Canada - English - Health Canada

fresenius kabi canada ltd - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems

Canada - English - Health Canada

hikma canada limited - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems

Canada - English - Health Canada

juno pharmaceuticals corp. - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems

Canada - English - Health Canada

dr reddy's laboratories ltd - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g - carbapenems

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ertapenem as sodium - powder for solution for inj/inf - ertapenem as sodium 1 g/vial - ertapenem - ertapenem s.k. is indicated for the treatment of adult patients and pediatric patients ( 3 months of age and older) with the following moderate to severe infections caused by susceptible isolates of the designated microorganisms. - complicated intra-abdominal infections. - complicated skin and skin structure infections including diabetic foot infections without osteomyelitis. - community acquired pneumonia. - complicated urinary tract infections including pyelonephritis. acute pelvic infections including postpartum endomyometritis septic abortion and post surgical gynecologic infections

Canada - English - Health Canada

eugia pharma inc. - ertapenem (ertapenem sodium) - powder for solution - 1g - ertapenem (ertapenem sodium) 1g

Malta - English - Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - ertapenem sodium - concentrate for solution for infusion - ertapenem sodium 1 g - antibacterials for systemic use

Israel - English - Ministry of Health

inovamed pharma ltd, israel - ertapenem as monosodium - lyophilized powder for injection - ertapenem as monosodium 1 g/vial - ertapenem - ertapemed is indicated for the treatment of adult patients and pediatric patients (3 months of age and older) with the following moderate to severe infections caused by susceptible isolates of the designated microorganisms. - complicated intra-abdominal infections. - complicated skin and skin structure infections including diabetic foot infections without osteomyelitis. - community acquired pneumonia. - complicated urinary tract infections including pyelonephritis. acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections